Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003279054 | SCV004002890 | uncertain significance | Cardiovascular phenotype | 2023-05-02 | criteria provided, single submitter | clinical testing | The p.E4061V variant (also known as c.12182A>T), located in coding exon 29 of the APOB gene, results from an A to T substitution at nucleotide position 12182. The glutamic acid at codon 4061 is replaced by valine, an amino acid with dissimilar properties. This alteration has been reported in a hypertriglyceridemia cohort (Gill PK et al. J Clin Lipidol, 2021 Nov;15:79-87). This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |